Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stake Lifted by ProShare Advisors LLC
ProShare Advisors LLC grew its holdings in shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) by 29.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,229 shares of the company’s stock after purchasing an additional 2,788 shares during the […]
